ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic

NCT04329195 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

44

Enrollment

OTHER

Sponsor class

Stopped insufficient recrutment

Conditions

History of Cardiovascular Disease Treated With RAS Blockers and With SARS-CoV-2 Infection

Interventions

DRUG: 1: discontinuation of RAS blocker therapy
DRUG: 2: continuation of RAS blocker therapy

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]